FDA Study Finds Many CBD Products Are Mislabeled

The FDA has found that many products containing CBD are mislabeled and contain significantly more or less CBD than advertised, reports Food Business News. A preliminary study by the organization found that nearly a quarter of food products did not meet their label claims. The FDA randomly tested 200 tinctures, oils, capsules, edibles, drinks, and pet products containing CBD. Nearly half were found to contain THC, the psychoactive ingredient of cannabis. Of the 20 food and beverage products tested that had a specific amount of CBD listed on the label,…

Read More

FDA Investigates Multistate Outbreak of Cyclospora Infections

The FDA, along with the CDC, state, and local partners, are investigating a multistate outbreak of Cyclospora infections potentially linked to Aldi, Hy-Vee, Walmart, and Jewel-Osco grocery store brand salads containing iceberg lettuce, red cabbage, and carrots. Aldi’s Little Salad Bar Brand Garden Salads, Hy-Vee’s Garden Salad, Jewel-Osco’s Signature Farms Garden Salad, and Walmart’s Marketside Classic Iceberg Salad have been recalled. All of the recalled salads were sold in mid-western states. Fresh Express is the manufacturer of each of these recalled salads. In a statement, the FDA said that it…

Read More

NAOOA Files Standard of Identity Petition with FDA

The North American Olive Oil Association has filed a standard of identity petition with the FDA that would eliminate confusion among consumers and promote fair dealing in the industry. This follows a citizen petition filed by the association and olive oil producer Deoleo filed last November. The petition includes the results of a survey of 1,500 U.S. consumers about their perceptions of olive oil. The findings show that there is significant confusion among consumers around the meanings of “virgin” or “refined” cooking oil, as well as where olive oil actually…

Read More

FDA Issues Additional Guidance Relaxing Food Labeling Requirements

The FDA has issued another guidance document to provide temporary flexibility in food labeling requirements to manufacturers and vending machine operators. The goal is provide temporary flexibility to minimize the impact of supply chain disruptions amid the COVID-19 pandemic. The guidance outlines the flexibility for manufacturers to make minor formulation changes in certain circumstances without making conforming label changes, and existing flexibilities in food labeling regulations. In addition, it provides flexibility to vending machine labeling requirements so they do not have to provide calorie information for foods sold in vending…

Read More

USDA, FDA Partner to Prevent Food Chain Interruptions

The USDA and the FDA have created a Memorandum of Understanding to help prevent interruptions at FDA-regulated food facilities, including fruit and vegetable processing. The MOU creates a process for the two agencies to determine which circumstances the USDA could exercise its authority under the Defense Production Act with domestic food resource facilities that manufacture, process, pack, or hold foods, as well as those that grow or harvest food, which are normally under the FDA’s jurisdiction. A joint statement from Mindy Brashears, Ph.D., USDA under secretary for food safety, and…

Read More

FDA authorizes production of a new ventilator that costs up to 25x less than existing devices – TechCrunch

The U.S. Food and Drug Administration (FDA) has authorized the manufacture of the Coventor ventilator, a new hardware design first developed by the University of Minnesota. The project sought to create a ventilator that could provide the same level of life-saving care as existing ventilator models, but with a much lower cost to help ramp production quickly and make them affordable to the health institutions that need them. The Coventor becomes the first of these types of novel ventilator designs to earn an Emergency Use Authorization (EUA) from the FDA.…

Read More

FDA Loosens Labeling Requirements | News

The FDA has issued three guidance documents to help food manufacturers, retailers, and restaurants meet consumers’ food needs during the COVID-19 pandemic, reports Food Business News. The documents temporarily relax certain food labeling rules that could slow down the supply chain and limit consumer access to food. The first document, issued March 26, relaxes nutrition labeling rules for restaurants seeking to sell packaged food to consumers, food manufacturers with inventory intended for foodservice, and manufacturers when retail packaging for certain foods is unavailable. In this case, the FDA said it…

Read More

FDA Shifts to Remote FSVP Inspections

The FDA will begin requesting that importers send records required under the Foreign Supplier Verification Programs for Importers of Food for Humans and Animals rule, electronically to the agency as it shifts to conducting inspections remotely during the COVID-19 pandemic. Until now, FSVP inspections have typically been conducted at an importer’s place of business. However, under the FSVP regulation, the FDA has the authority to make written requests for importers to provide records to the agency electronically or by other prompt means. Because of the travel restrictions, social distancing, and…

Read More

Mesa Biotech gains emergency FDA approval for rapid, point-of-care COVID-19 test – TechCrunch

The U.S. Food and Drug Administration (FDA) is making use of its Emergency Use Authorization (EUA) powers to expand the pool of available COVID-19 testing resources in the U.S., and now you can add another rapid test that delivers results in just 30 minutes to the list. Mesa’s test is also small enough to be able to be used right at the frontline of care, including in clinics and hospitals, with multiple tests able to be run in parallel. Mesa’s rapid test follows one from Cepheid that was approved on…

Read More

FDA Postpones Domestic Routine Surveillance Inspections

The FDA has temporarily postponed all domestic routine surveillance inspections due to the coronavirus outbreak. These are facility inspections that the FDA traditionally conducts every few years based on a risk analysis. All domestic for-cause inspections will be evaluated and will proceed if mission-critical. In a statement, FDA commissioner Stephen M. Mahn, M.D., said, “The FDA remains committed to using all available tools to oversee the safety and quality of FDA-regulated products for American patients and consumers. As this remains a dynamic situation, we will continue to assess and calibrate…

Read More